HURA
トゥフラ・バイオサイエンシズ
TuHURA Biosciences, Inc.
通常取引データ（自動更新なし）RVOL 0.8xDV $470,15720日平均DV $578,746?
Earnings 2026-11-1352W high -28.0%52W low +502.4%Fwd PER 30.9xMarket cap $138MAvg volume 243K
Company Overview
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q2 | -0.14 | $0 | -$9M |
| 2026 Q1 | -0.13 | $0 | -$4M |
| 2025 Q4 | -0.13 | $0 | -$6M |
| 2025 Q3 | -0.14 | $0 | -$11M |
| 2025 Q2 | -0.21 | $0 | -$6M |
| 2025 Q1 | -0.15 | $0 | -$5M |
| 2024 Q4 |
